BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Opazo-Ríos L, Tejera-Muñoz A, Soto Catalan M, Marchant V, Lavoz C, Mas Fontao S, Moreno JA, Fierro Fernandez M, Ramos R, Suarez-Alvarez B, López-Larrea C, Ruiz-Ortega M, Egido J, Rodrigues-Díez RR. Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice. Front Pharmacol 2022;13:778776. [PMID: 35370692 DOI: 10.3389/fphar.2022.778776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fernández C, Marchant V, Donate-Correa J, Navarro-González JF, Ortiz A, Ruiz-Ortega M. Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int 2023;103:282-96. [PMID: 36470394 DOI: 10.1016/j.kint.2022.10.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yang M, Chen W, He L, Liu D, Zhao L, Wang X. A Glimpse of necroptosis and diseases. Biomedicine & Pharmacotherapy 2022;156:113925. [DOI: 10.1016/j.biopha.2022.113925] [Reference Citation Analysis]
3 Jianbing H, Xiaotian L, Jie T, Xueying C, Honge J, Bo Z, Lirong H, Lei Z. The Effect of Allograft Inflammatory Factor-1 on Inflammation, Oxidative Stress, and Autophagy via miR-34a/ATG4B Pathway in Diabetic Kidney Disease. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/1668000] [Reference Citation Analysis]